Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1
Home
>
Research Projects
>
Strategy 3 : HTA Research > Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1